找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Glaucoma Surgery; Treatment and Techni Luigi Caretti,Lucio Buratto Book 2018 Springer International Publishing AG 2018 Micro-Invasive Glauc

[復(fù)制鏈接]
樓主: Limbic-System
31#
發(fā)表于 2025-3-26 21:05:30 | 只看該作者
Hypernovae and Gamma-Ray Bursts,Glaucoma Drainage Devices (GDDs) or shunts were proposed by Molteno and coll in 1968 for the treatment of refractory glaucomas, meaning those cases at a high risk of failure following filter surgery or in cases in which surgery was already not successful.
32#
發(fā)表于 2025-3-27 01:40:58 | 只看該作者
https://doi.org/10.1007/b117116In recent years, we have seen large development of laser technology in ophthalmology.
33#
發(fā)表于 2025-3-27 08:00:01 | 只看該作者
Interactive Data Selection in Power View,Following detailed and correct diagnosis, the best procedure for the treatment of glaucoma is chosen on the basis of:
34#
發(fā)表于 2025-3-27 10:30:22 | 只看該作者
Anatomy,In glaucoma surgery, comprehensive knowledge and understanding of the sclero-corneal limbus and the anatomy of the irido-corneal angle (Figs. 1.1, 1.2, 1.3, 1.4, 1.5, and 1.6) are absolutely essential.
35#
發(fā)表于 2025-3-27 17:41:05 | 只看該作者
Anesthesia,The anesthesia used in a surgical procedure for glaucoma depends primarily on the surgeon’s personal preferences. However, the complexity of the surgical procedure, the presence of other systemic clinical conditions and patient collaboration also play important roles.
36#
發(fā)表于 2025-3-27 19:22:15 | 只看該作者
37#
發(fā)表于 2025-3-27 21:58:02 | 只看該作者
Laser Antiglaucomatous Treatments,In recent years, we have seen large development of laser technology in ophthalmology.
38#
發(fā)表于 2025-3-28 02:13:01 | 只看該作者
The Choice of Glaucoma Treatment,Following detailed and correct diagnosis, the best procedure for the treatment of glaucoma is chosen on the basis of:
39#
發(fā)表于 2025-3-28 09:48:49 | 只看該作者
High energy neutrino and gamma-ray astronomy compliance to treatment. Several surgical options are available; they have different degrees of efficacy and also different complication rates. The decision regarding the treatment pathway is taken on a case by case basis, and this makes a standard treatment protocol difficult to define.
40#
發(fā)表于 2025-3-28 13:53:42 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 20:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
青冈县| 崇明县| 海口市| 宁阳县| 融水| 阜新| 孟州市| 集安市| 巴马| 马公市| 成安县| 贵港市| 奉节县| 崇信县| 娄烦县| 文安县| 禄丰县| 邛崃市| 天祝| 桐乡市| 德阳市| 马龙县| 辽阳市| 兴业县| 横山县| 天祝| 邹城市| 泾川县| 屏东县| 永和县| 广宁县| 岑巩县| 贡觉县| 梁河县| 杂多县| 金秀| 富宁县| 个旧市| 乐昌市| 图片| 通河县|